Moxe’s key product, Substrate, is an EMR integration solution that directly links payers and their provider networks. It allows providers to incorporate claims, risk and other payer data into their analytic efforts.
Moxe Health will use the financing round’s proceeds for product expansion, hiring and sales efforts.
“The rules of healthcare are quickly being re-written, as technology presents an opportunity to facilitate more meaningful interactions between payers and providers,” said Dan Wilson, Moxe’s founder and CEO. “We enable workflows that are beneficial to both sides of the equation and focus on delivering patient health insights to providers while reducing administrative excess. We balance this by offering payers a cost-effective model for receiving clinical data, at a fraction of the standard market rate.”
More articles on health IT:
Balancing technology with healthcare’s human narrative: A Q&A with Dr. Abha Agrawal
Organizations largely unconfident in data breach response plans: 7 key findings from Ponemon Institute
Vizient taps M*Modal for transcription services
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
